Mid-Year Report — EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC. (2007)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

EXPRESS SCRIPTS, INC.

Client

EXPRESS SCRIPTS, INC.

Income

—

Expenses

$390,000

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
Mid-Year Report (this page)	Aug 10, 2007	$390,000	Replaced
Mid-Year Amendment	Nov 29, 2007	$490,000	Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Items related to fully funding the pharmacy benefit under the military health system--2008 Defense Authorization bills (HR 1585/S 1547. Promoting TRICARE's mail order program--HR 2319

Lobbyist	Covered position, as disclosed
MARY M ROSADO	N/A

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Food & Drug Administration (FDA)

Bills named: H.R. 2319 (110th), H.R. 1585 (110th)

Labor Issues/Antitrust/Workplace LBR

Providing an antitrust exemption for pharmacies--HR 971/ S 885

Lobbyist	Covered position, as disclosed
MARY M ROSADO	N/A

Contacted: Food & Drug Administration (FDA); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 971 (110th)

Issues relating to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act Issues related to Medicare Part B and Part D: S. 870/HR 2567 to provide coverage of home infusion services and supplies under Medicare. Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/HR 976 (senate bill)); direct negotiation (HR 4/ S 1); electronic prescribing; various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)

Lobbyist	Covered position, as disclosed
MARY M ROSADO	N/A

Contacted: White House Office; SENATE; Defense, Dept of (DOD); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 870 (110th), H.R. 4 (110th), H.R. 2770 (110th), H.R. 976 (110th), H.R. 2567 (110th), H.R. 1474 (110th), H.R. 3162 (110th)

Pharmacy PHA

S 1082/HR 2900--FDA reauthorization (follow on biologics, citizens petition reform, pediatric exclusivity reform, pedigree) S. 623/HR 1038/HR 1956--Regulatory pathway for generic biologics S 1088/S 25/S 28/S 316/ HR 1902--Issues relating to bringing generics to market in a timely fashion S 1376/HR 2606--expansion of 340b pricing

Lobbyist	Covered position, as disclosed
MARY M ROSADO	N/A

Contacted: White House Office; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 623 (110th), H.R. 1956 (110th), H.R. 1038 (110th), H.R. 2606 (110th), H.R. 2900 (110th), H.R. 1902 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.